FRI0218 Shared epitope positivity is related to efficacy of abatacept in rheumatoid arthritis
BackgroundAbatacept, a soluble fusion protein composed of the extracellular domain of CTLA-4 molecule and the Fc portion of human IgG1, is approved therapy for RA by the mechanism of binding to CD80/86 (B7–1/B7–2) on antigen presenting cell (APC), and blocking the B7:CD28 interaction. Meanwhile, it...
Saved in:
Published in | Annals of the rheumatic diseases Vol. 76; no. Suppl 2; p. 565 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
London
BMJ Publishing Group LTD
01.06.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!